Systemic Inflammatory Markers Predicting the Overall Survival of Patients Using Tyrosine Kinase Inhibitors in the First-line Treatment of Metastatic Renal Cell Carcinoma.

Korkmaz, Mustafa; Erylmaz, Melek Karakurt

Korkmaz, Mustafa; Erylmaz, Melek Karakurt.

Afiliación

Korkmaz M; Department of Medical Oncology, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkiye.
Erylmaz MK; Department of Medical Oncology, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkiye.

J Coll Physicians Surg Pak ; 33(6): 653-658, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37300261

Asunto(s)

Carcinoma de Células Renales; Neoplasias Renales; Humanos; Carcinoma de Células Renales/patología; Sunitinib/uso terapéutico; Neoplasias Renales/patología; Pronóstico; Inflamación; Proteína C-Reactiva; Neutrófilos/patología; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Coll Physicians Surg Pak Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google